In a newly published study, researchers call for clinical trials of an FDA-approved heart medication.
FUJIFILM Diosynth Biotechnologies, a Texas A&M University System subcontractor, will mass produce vaccines as part of an agreement between the federal government and the Center for Innovation in Advanced Development and Manufacturing.
Thirty-one percent of respondents to a Texas A&M-led survey said they don’t intend to be vaccinated against COVID-19.
During a time of social isolation, a Texas A&M expert says COVID-19 has also interrupted the way we grieve.
Research from Texas A&M shows how the COVID-19 pandemic has affected consumer travel perceptions and priorities.
A health economist from the Texas A&M School of Public Health sheds light on the “economic shock” caused by the pandemic and its impact on anesthesiologists’ practices.
David Brenner, a Texas A&M expert in German and European studies, explains the cultural reasons that may have contributed to Germany's containment of the coronavirus.
Industry experts say they hope the worst of the COVID-19-related disruptions are behind them.
The unique retirement home for pets continues to provide 24-hour care for animals during the COVID-19 pandemic.
Texas A&M engineering researchers seek to develop a ventilation control system to reduce the spread of the coronavirus in public buildings.
Virtual services, including telemedicine, have allowed providers to care for patients at home.
Texas A&M School of Public Health experts explain the effort to prevent COVID-19 from rebounding as the state reopens.
Students are learning how veterinarians around the state have changed their processes during COVID-19, and are creating disaster plans for their future practices.